Clinical Trial

Gravity Stroke System for Recanalization of Large Vessel Occlusion Strokes

Name: Gravity Stroke System for Recanalization of Large Vessel Occlusion Strokes — clinical trial record (NCT07335185)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GRASSROOT Reg

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Supernova and Neutron are endovascular mechanical revascularization devices indicated to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing an acute ischemic stroke within 24 hours of symptom onset or from last known well time.

Trial Details

NCT Number	NCT07335185
Lead Sponsor	Gravity Medical Technology, INC
Conditions	Stroke, Ischemic Stroke, Cerebrovascular Disorders, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Vascular Disease
Enrollment	3,000 participants
Start Date	2026-01-01
Primary Completion	2030-10-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-13